文献速递垂体与肾上腺疾病

生长激素缺乏症的遗传学:来自203例患者队列的见解

Genetics of GH Deficiency: Insights From a Cohort of 203 Patients.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该多中心队列纳入203例生长激素缺乏症患者(78例孤立性、125例联合性垂体激素缺乏),采用Sanger测序和全外显子测序筛查184个相关基因。23.2%的患者发现遗传病因(孤立性9.0%、联合性32.0%),PROP1突变占14.8%,87.8%患者携带意义不明变异。

要点

  • 203例中23.2%发现遗传病因,联合性垂体激素缺乏者达32.0%
  • PROP1突变最常见,占全部患者的14.8%
  • 87.8%患者携带意义不明变异,相当比例仍未获遗传诊断

核心结论

  • 本研究揭示多个新发和复发突变,扩展了生长激素缺乏症的遗传谱,并强调该病的遗传异质性。
  • 相当比例患者仍未获遗传诊断,提示可能涉及其他未知的遗传、表观遗传或环境因素。

研究设计与样本

  • 葡萄牙多中心队列,纳入203例生长激素缺乏症患者,其中孤立性生长激素缺乏78例、联合性垂体激素缺乏125例。
  • 采用Sanger测序和全外显子测序筛查184个生长激素缺乏症相关基因。

主要发现

  • 23.2%的患者发现遗传病因,孤立性生长激素缺乏为9.0%,联合性垂体激素缺乏为32.0%。
  • 突变见于PROP1(14.8%的患者)、GLI2(2.0%)、KMT2D(1.0%)、PROK2(1.0%)、PROKR2(1.0%)、CDON(0.5%)、COL1A2(0.5%)、COL2A1(0.5%)、GHRHR(0.5%)、PTPN11(0.5%)和SOX3(0.5%)基因。
  • 1例患者(0.5%)携带BMP4和NF1双基因突变。
  • 87.8%的患者发现意义不明变异。

关键数值与推荐

  • 罕见序列变异的定义:人群最大等位基因频率<0.01。

局限性

  • 相当比例患者仍未获遗传诊断,提示可能涉及其他未知的遗传、表观遗传或环境因素。
  • 作者指出需进一步研究以阐明潜在机制并识别其他致病因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: GH deficiency is a rare disorder characterized by severe short stature, which can result from genetic mutations affecting hypothalamic-pituitary development and function. OBJECTIVE: To determine the genetic basis of GH deficiency in a Portuguese cohort. DESIGN, SETTING, PATIENTS: Multicenter cohort of 203 GH-deficient patients (78 with isolated GH deficiency and 125 with combined pituitary hormone deficiency) were analyzed. INTERVENTION: Screening of a panel of 184 GH deficiency-related genes using Sanger sequencing and whole exome sequencing. MAIN OUTCOME MEASURE: Rare sequence variants (population maximum allele frequency <0.01). RESULTS: A genetic cause was identified in 23.2% of patients (9.0% in isolated GH deficiency and 32.0% in combined pituitary hormone deficiency). Mutations were found in the PROP1 (14.8% of patients), GLI2 (2.0%), KMT2D (1.0%), PROK2 (1.0%), PROKR2 (1.0%), CDON (0.5%), COL1A2 (0.5%), COL2A1 (0.5%), GHRHR (0.5%), PTPN11 (0.5%), and SOX3 (0.5%) genes. One patient (0.5%) had a digenic mutation in the BMP4 and NF1 genes. Variants of uncertain significance were identified in 87.8% of patients. CONCLUSION: This study revealed several novel and recurrent mutations that expand the genetic spectrum of GH deficiency and underscore the genetic heterogeneity of this disorder. A significant proportion of patients remained genetically undiagnosed, suggesting the involvement of additional unknown genetic, epigenetic, or environmental factors. These findings contribute to the understanding of the genetic architecture of GH deficiency and highlight the need for further investigations to elucidate underlying mechanisms and identify additional causative factors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ribeiro AC, Coutinho E, Syed N, et al. Genetics of GH Deficiency: Insights From a Cohort of 203 Patients. J Clin Endocrinol Metab. 2026. PMID: 40554621. doi:10.1210/clinem/dgaf377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。